CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 88 filers reported holding CUREVAC N V in Q2 2024. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $34,503 | -22.9% | 11,387 | +7.1% | 0.00% | – |
| Q4 2023 | $44,765 | -65.3% | 10,633 | -14.1% | 0.00% | -100.0% |
| Q2 2023 | $128,968 | +118.2% | 12,377 | +46.0% | 0.00% | – |
| Q1 2023 | $59,099 | -37.1% | 8,479 | -28.8% | 0.00% | -100.0% |
| Q3 2022 | $94,000 | -95.6% | 11,915 | -92.5% | 0.00% | -92.3% |
| Q2 2022 | $2,157,000 | +78.3% | 158,520 | +156.8% | 0.01% | +30.0% |
| Q1 2022 | $1,210,000 | +499.0% | 61,719 | +945.9% | 0.01% | +400.0% |
| Q4 2021 | $202,000 | -72.0% | 5,901 | -55.3% | 0.00% | -77.8% |
| Q3 2021 | $721,000 | -67.8% | 13,206 | -56.7% | 0.01% | -64.0% |
| Q2 2021 | $2,242,000 | +117.7% | 30,506 | +140.2% | 0.02% | +78.6% |
| Q4 2020 | $1,030,000 | – | 12,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 370,385 | $17,241,000 | 4.81% |
| Novo Holdings A/S | 201,642 | $9,386,000 | 0.47% |
| Vivo Capital, LLC | 169,825 | $7,905,000 | 0.46% |
| Baillie Gifford | 3,896,475 | $181,381,000 | 0.12% |
| DekaBank Deutsche Girozentrale | 435,500 | $21,707,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 69,176 | $3,220,000 | 0.08% |
| HHLR ADVISORS, LTD. | 186,183 | $8,667,000 | 0.07% |
| Pinz Capital Management, LP | 3,600 | $168,000 | 0.06% |
| Cutler Group LLC / CA | 18,400 | $856,000 | 0.05% |
| ETF MANAGERS GROUP, LLC | 35,722 | $1,632,000 | 0.05% |